Abstract
A histochemical study with the fluorescence method showed that administration of cannabis sublimate administered to rats increased the noradrenaline content of the terminal axonal varicosities of the hypothalamus, probably caused by a facilitation of noradrenaline uptake. The findings are discussed in relation to other known effects of cannabis derivatives, hypothermia, increased appetite and prolongation of amphetamine action.
Similar content being viewed by others
References
Anden, N. E., Dahlström, A., Fuxe, K., Larsson, K.: Mapping out of catecholamine and 5-hydroxytryptamine neurons innervating the telencephalon and diencephalon. Life Sci. 4, 1275–1279 (1965).
Bertler, A., Falck, B., Owman, C., Rosengren, E.: The localisation of monoaminergic blood-brain barrier mechanisms. Pharmacol. Rev. 18, 369–385 (1966).
Bircher, H. I., Mechoulam, R.: Pharmacological effects of two active constituents of marihuana. Arch. int. Pharmacodyn. 172, 24–31 (1968).
Boyd, E. S., Meritt, D. A.: Effects of thiopental and a tetrahydrocannabinol derivative on arousal and recruiting in the cat. J. Pharmacol. exp. Ther. 149, 138–145 (1965).
— —: Effects of barbiturates and a tetrahydrocannabinol derivative on recovery cycles of medial lemniscus, thalamus and reticular formation in the cat. J. Pharmacol. exp. Ther. 151, 376–384 (1966).
Carlsson, A., Falck, B., Hillarp, N. A., Torp, A.: Histochemical localisation at the cellular level of hypotalamic noradrenaline. Acta physiol. scand. 54, 385–386 (1962).
—, Fuxe, K., Hamberger, R., Lindqvist, M.: Biochemical and histochemical studies on the effects of imipramine like drugs and amphetamine on central and peripheral catecholamine neurons. Acta physiol. scand. 67, 481–497 (1966).
Constantinidis, J., Bartholini, G., Tissot, R., Pletscher, A.: Elective Anreicherung von Dopamine im Parenchym des Rattenhirns. Helv. physiol. pharmacol. Acta 25, 411–415 (1967).
Dagirmanjian, R., Boyd, E. S.: Some pharmacological effects of two tetrahydrocannabinols. J. Pharmacol. exp. Ther. 135, 25–33 (1962).
—, Hodge, H. C.: Are biogenic amines involved in the mecanism of action of the tetrahydrocannabinols? Agents and Actions 2, 46–48 (1969).
Dahlström, A., Fuxe, K.: Evidence for the existence of monoamine-containing neurons in the central nervous system. Acta physiol. scand. 62, suppl. 232 (1964).
Efron, D. H.: Marihuana: a few problems. In: Psychopharmacology. A Review of Progress 1957–1967, D. H. Efron, ed. (Public Health Service Public. No. 1836, USA), p. 1269 (1968).
Falck, B., Hillarp, N. A., Thieme, G., Torp, A.: Fluorescence of catecholamines and related compounds condensed with formaldehyde. J. Histochem. Cytochem. 10, 348–354 (1962).
—, Owman, C.: A detailed methodological description of the fluorescence method for the cellular demonstration of biogenic monoamines. Acta Univ. (Lund.) II, 7 (1965).
Feldberg, W., Myers, R. D.: A new concept of temperature regulation by amines in the hypothalamus. Nature (Lond.) 200, 1325 (1963).
— —: Change in temperature produced by microinjections of amines into the anterior hypothalamus of cats. J. Physiol. (Lond.) 177, 239–245 (1965).
Freedman, D. X.: Psychomimetic drugs and brain biogenic amines. Amer. J. Psychiat. 119, 843–850 (1963).
Fuxe, K., Ungerstedt, U.: Histochemical studies on the distribution of catecholamines and 5-hydroxytryptamine after intraventricular injection. Histochemie 13, 16–28 (1968a).
— —: Histochemical studies on the effect of (+)-amphetamine, drugs of the imipramine group and tryptamine on central catecholamine and 5-hydroxytryptamine neurons after intraventricular injection of catecholamines and 5-hydroxytryptamine. Europ. J. Pharmacol. 4, 135–144 (1968b).
Garrattini, S.: Effects of a cannabis extract on gross behaviour. In: Hashish: its Chemistry and Pharmacology, CIBA Found., Study Group No. 21, p. 70. London: J. A. Churchill 1965.
Garriott, J. C., Forney, R. B., Hughes, F. W., Richards, A. B.: Pharmacological properties of some cannabis related compounds. Arch. int. Pharmacodyn. 171, 425–434 (1968).
—, King, L. J., Forney, R. B., Hughes, F. W.: Effects of some tetrahydrocannabinols on hexobarbital sleeping time and amphetamine induced hyperactivity in mice. Life Sci. 6, 2119–2128 (1967).
Goodman, L. S., Gilman, A.: Cannabis (Marihuana). In: The Pharmacological basis of Therapeutis, 3th Ed., p. 299. New York: MacMillan 1965.
Grossman, S. P.: Amer. J. Physiol. 202, 872 (1962); cited by S. R. Sommer, D. Novin and M. Levin,: Food and water intake after intrahypothalamic injections of carbachol in the rabbit. Science 156, 883–884 (1967).
Hayden, J. F., Johnson, L. R., Maickel, M. P.: Construction and implantation of permanent cannula for making injections into the lateral ventricle of rat brain. Life Sci. 5, 1509–1515 (1966).
Holtzmann, D., Lovell, R. A., Jaffe, J. H., Freedmann, D. X.: 1-delta 9-tetrahydrocannabinol: neurochemical and behavioral effets in the mouse. Science 163, 1464–1467 (1969).
Isbell, H., Gorodetzsky, C. W., Jasinski, D., Claussen, U., Spulak, F. v., Korte, F.: Effects of (−) delta-9-trans-tetrahydrocannabinol in man. Psychopharmacologia (Berl.) 11, 184–188 (1967).
Joachimoglou, G.: Natural and smoked hashish. In: Hashish: its Chemistry and Pharmacology. Ciba Found., Study Group No. 21, p. 2. London: J. A. Churchill 1965.
Kubena, R. K., Barry, H.: Interactions of delta 1-tetrahydrocannabinols with barbiturates and methamphetamine. J. Pharmacol. exp. Ther. 173, 94–100 (1970).
Miras, C. J.: Some aspects of cannabis actions. In: Hashish: its Chemistry and Pharmacology, Ciba Found., Study Group No. 21, p. 37. London: J. A. Churchill 1965.
—: Experience with chronic hashish smokers. In: Drugs and Yuth, p. 191. New York: Ch. C. Thomas 1969.
- Kephalas, T. A., Papadakis, D. P.: The effect of hashish extract on the norepinephrine in rabbit brain. Narcotic's Bull. (in press).
Robertis, E., de, Iraldi, A. P., de, Lores-Arnaiz, G. R., de, Zieher, L. M.: Synaptic vesicles from the rat hypothalamus. Isolation and norepinephrine content. Life Sci. 4, 193–201 (1965).
Scheckel, C. L., Boff, E., Dahlen, P., Smart, T.: Behavioral effects in monkeys of racemate of two biologically active marihuana constituents. Science 160, 1467–1469 (1968).
Silva, M. T., Carlini, E. A., Claussen, U., Korte, F.: Lack of cross-tolerance in rats among (−) delta 9-trans-tetrahydrocannabinol (delta-9-THC), cannabis extract, mescaline, and lysergic acid diethylamid (LSD-25). Psychopharmacologia (Berl.) 13, 332–340 (1968).
Smith, C. B.: Effects of D-amphetamine upon brain amine content and locomotor activity of mice. J. Pharmacol. exp. Ther. 147, 96–102 (1965).
Vieira, F. J. A., Aguiar, M. B., Alencar, J. W., Seabra, A. P., Tursch, B. M., Leclercq, J.: Effects of the organic layer of hashish smoke extract and preliminary results of its chemical analysis. Psychopharmacologia (Berl.) 10, 361–362 (1967).
Watt, I. M.: Drug dependence of hashish type. In: Hashish: its chemistry and pharmacology. Ciba Found., Study Group No. 21, p. 54. London: J. A. Churchill 1965.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Constantinidis, J., Miras, C.J. Effect of hashish smoke sublimate on hypothalamic noradrenaline studied by the fluorescence method. Psychopharmacologia 22, 80–90 (1971). https://doi.org/10.1007/BF00401470
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00401470